Global Point of Care Molecular Diagnostics Market : Industry Size, Share, Analysis, Trend & Future Planning 2023
Bharat Book Bureau Provides the Trending Market Research Report on “Global Point of Care Molecular Diagnostics Market, Forecast to 2023” underLife Sciences category. The report offers a collection of superior market research, market analysis, competitive intelligence and industry reports.
Global POC Molecular Diagnostics Market is projected to grow at aCAGR of 14.7%
The global point of care (POC) molecular diagnostics market is expected to reachUSD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. However, inadequate reimbursement and stringent regulatory policies are likely to restrain the growth of this market during the forecast period.
Request a free sample copy ofPoint of Care Molecular Diagnostics MarketReport @ https://www.bharatbook.com/MarketReports/Sample/Reports/1084760
The INAAT technology is expected to grow at highest CAGR during the forecast period
Based on technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and other technologies. The INAAT segment is expected to grow at highest CAGR during the forecasted period. The increasing popularity of INAAT for infectious diseases diagnosis is expected to drive this market in the coming years.
Asia Pacific is projected to grow at the highest CAGR during the forecast period
While North America is expected to account for the largest share of the global POC molecular diagnostics market, Asia Pacific is projected to grow at the highest CAGR during the study period. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.
Break-up profile of primaries:
- By Company Type- Tier 40%, Tier 30%, and Tier 30%
- By Designation-C-level-27%, D-level-18%, and Others-55%
- By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%
The key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher (US), Biomerieux (France), and Meridian Biosciences (US).
Click the link below to read the Full report :
About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on: Twitter, Facebook, LinkedIn, Google Plus
OPKO Health (Nasdaq: OPK) and Pfizer (NYSE: PFE) Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency
**Disclaimer: Crown Equity Holdings Inc. has received $5,000.00 (five thousand dollars) in cash from Nass Valley Gateway Ltd. (CSE:NVG) (FSE:3NVN) for 30 days of advertisement services